GoodRx Holdings, Inc. - Common Stock (GDRX)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
117,322,482
Share change
-3,032,831
Total reported value
$496,241,949
Put/Call ratio
69%
Price per share
$4.23
Number of holders
156
Value change
-$16,420,845
Number of buys
72
Number of sells
107

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2025

As of 30 Sep 2025, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 156 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 117,322,482 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, Silver Lake Group, L.L.C., RENAISSANCE TECHNOLOGIES LLC, Petrus Trust Company, LTA, DIMENSIONAL FUND ADVISORS LP, LSV ASSET MANAGEMENT, BlackRock, Inc., and Technology Crossover Management X, Ltd.. This page lists 156 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.